Home Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
 

Keywords :   


Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say

2015-03-05 00:53:04| Biotech - Topix.net

Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.

Tags: year say sell reports

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
More »